Active site binding modes of curcumin in HIV-1 protease and integrase

被引:100
|
作者
Vajragupta, O
Boonchoong, P
Morris, GM
Olson, AJ
机构
[1] Mahidol Univ, Fac Pharm, Dept Pharmaceut Chem, Bangkok 10400, Thailand
[2] Ubon Rajathanee Univ, Fac Pharmaceut Sci, Div Pharmaceut Chem & Technol, Ubon Ratchathani 34190, Thailand
[3] Scripps Res Inst, Dept Mol Biol, Mol Graph Lab, La Jolla, CA 92037 USA
关键词
curcumin; HIV-1; HIV integrase; HIV protease; 5-CITEP; docking;
D O I
10.1016/j.bmcl.2005.05.032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure models for the interaction of curcumin with HIV-1 integrase (IN) and protease (PR) were investigated using computational docking. Curcumin was found to bind preferentially in similar ways to the active sites of both IN and PR. For IN, the binding site is formed by residues Asp64, His67, Thr66, Glu92, Thr93, Asp116, Ser119, Asn120, and Lys159. Docked curcumin contacts the catalytic residues adjacent to Asp116 and Asp64, and near the divalent metal (Mg2+). In the PR docking, the curcumin structure fitted well to the active site, interacting with residues Asp25, Asp29, Asp30, Gly27', Asp29', and Asp30'. The results suggest that o-hydroxyl and/or keto-enol structures are important for both IN and PR inhibitory actions. The symmetrical structure of curcumin seems to play an important role for binding to the PR protein, whereas the keto-enol and only one side of the terminal o-hydroxyl showed tight binding to the IN active site. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3364 / 3368
页数:5
相关论文
共 50 条
  • [21] Machine learning for HIV-1 protease cleavage site prediction
    Lumini, Alessandra
    Nanni, Loris
    PATTERN RECOGNITION LETTERS, 2006, 27 (13) : 1537 - 1544
  • [22] A reliable method for HIV-1 protease cleavage site prediction
    Nanni, L
    Lumini, A
    NEUROCOMPUTING, 2006, 69 (7-9) : 838 - 841
  • [23] Mapping of HIV-1 integrase preferences for target site selection with various oligonucleotides
    Snasel, Jan
    Rosenberg, Ivan
    Paces, Ondrej
    Pichova, Iva
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2009, 488 (02) : 153 - 162
  • [24] Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
    Fader, Lee D.
    Malenfant, Eric
    Parisien, Mathieu
    Carson, Rebekah
    Bilodeau, Francois
    Landry, Serge
    Pesant, Marc
    Brochu, Christian
    Morin, Sebastien
    Chabot, Catherine
    Halmos, Ted
    Bousquet, Yves
    Bailey, Murray D.
    Kawai, Stephen H.
    Coulombe, Rene
    LaPlante, Steven
    Jakalian, Araz
    Bhardwaj, Punit K.
    Wernic, Dominik
    Schroeder, Patricia
    Amad, Ma'an
    Edwards, Paul
    Garneau, Michel
    Duan, Jianmin
    Cordingley, Michael
    Bethell, Richard
    Mason, Stephen W.
    Boes, Michael
    Bonneau, Pierre
    Poupart, Marc-Andre
    Faucher, Anne-Marie
    Simoneau, Bruno
    Fenwick, Craig
    Yoakim, Christiane
    Tsantrizos, Youla
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (04): : 422 - 427
  • [25] Raltegravir: an integrase inhibitor for HIV-1
    Evering, Teresa H.
    Markowitz, Martin
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (03) : 413 - 422
  • [26] Mapping DNA-binding sites of HIV-1 integrase by protein footprinting
    Dirac, AMG
    Kjems, J
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (03): : 743 - 751
  • [27] Interpreting trends in the binding of cyclic ureas to HIV-1 protease
    Mardis, KL
    Luo, R
    Gilson, MK
    JOURNAL OF MOLECULAR BIOLOGY, 2001, 309 (02) : 507 - 517
  • [28] MOLECULAR MECHANICS ANALYSIS OF INHIBITOR BINDING TO HIV-1 PROTEASE
    SANSOM, CE
    WU, J
    WEBER, IT
    PROTEIN ENGINEERING, 1992, 5 (07): : 659 - 667
  • [29] The binding of HIV-1 protease inhibitors to human serum proteins
    Schön, A
    Ingaramo, MD
    Freire, E
    BIOPHYSICAL CHEMISTRY, 2003, 105 (2-3) : 221 - 230
  • [30] Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site
    Wielens, Jerome
    Headey, Stephen J.
    Jeevarajah, Dharshini
    Rhodes, David I.
    Deadman, John
    Chalmers, David K.
    Scanlon, Martin J.
    Parker, Michael W.
    FEBS LETTERS, 2010, 584 (08) : 1455 - 1462